A clinical trial which is a particular computer simulation and used in the development or regulatory evaluation of a medicinal product, device, or intervention is called as an In-Silico Clinical Trial. The behaviour of the drug or device reaction, when deployed in the general population or when used in particular circumstances can be predicted with the help of latest computer modelling. This process is helpful to protect the public from the unintended consequences of side effects and drug interactions. In silico trials may potentially protect public health, advance personalized treatment, and be executed quickly and for a fraction of the cost of a full scale live trial. In silico trials using advanced biological networks, or the organs on a chip technique would enable analysing on hundreds of thousands of drug candidates on billions of virtual human physiological models in seconds with supercomputers. It would make drug discovery faster than ever.
In-Silico Clinical Trial Related Journals
Journal of Clinical Medicine and Therapeutics, Journal of Clinical Trials, Journal of Cancer Clinical Trials, Journal of Developing Drugs, Clinical Trials, Contemporary Clinical Trials, Open Access Journal of Clinical Trials and International Journal Of Clinical Trials.
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2019 All rights reserved. iMedPub LTD Last revised : February 20, 2019